Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

Erlotinib Hydrochloride
DOI: 10.1097/jto.0b013e318227e8c6 Publication Date: 2011-10-04T21:06:56Z